LabCompass

Ricardo Melo Ferreira

Biochemistry, Genetics and Molecular Biology · Indiana University

Publications

109

Citations

2,226

Est. group size

~3

Recurring co-author estimate

Active years

29

Publishing since 1998

Research summary
AI-generated

Ricardo Melo Ferreira works at the intersection of molecular biology and medicine, studying how the body's tissues and cells respond in conditions such as kidney injury, cardiovascular disease, and severe infections like COVID-19. His research uses tools such as single-cell and spatial transcriptomics (techniques that measure gene activity in individual cells and their locations) as well as network models to understand disease mechanisms. Work spans both clinical outcomes (for example, after cardiac surgery) and basic biological analysis.

Single-cell and spatial transcriptomicsKidney injury and diseaseCardiovascular and cardiac surgery outcomesCritical care and disease severity markersBiological and genomic network modeling

Publication activity grew sharply from around 2020 and has remained high, averaging roughly 14 papers per year over the last five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 14.2/year recently
172018: 1 publication18192020: 9 publications202021: 15 publications212022: 22 publications22222023: 14 publications232024: 10 publications242025: 19 publications252026: 6 publications26
Publishes in
  • Journal of the American Society of Nephrology×27
  • bioRxiv (Cold Spring Harbor Laboratory)×15
  • Zenodo (CERN European Organization for Nuclear Research)×5
  • JCI Insight×4
  • Nature Communications×3

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile